GH1 and type 2 diabetes mellitus: Despite these reports, however, we did not find that GH treatment (0.3 mg/kg daily) provided any additional protection against T2DM in UCD‐T2DM rats when co‐administered with liraglutide, although other physiological effects were observed (see below).